Invesaro

Stocks AVXL Earnings

Earnings

Anavex Life Sciences Corp. (AVXL) earnings

Quarterly results of Anavex Life Sciences Corp. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when AVXL files with the SEC.

Latest quarter: Q3 FY2026

In Q3 FY2026 (ended June 30, 2026) Anavex Life Sciences Corp. reported revenue of - and net income of $7.8M.

Diluted earnings per share were $0.08.

Net income by quarter
Q4 24: -$11.6M -$11.6M Q4 24Q1 25: -$12.1M -$12.1M Q1 25Q2 25: -$11.2M -$11.2M Q2 25Q3 25: -$13.2M -$13.2M Q3 25Q4 25: -$9.8M -$9.8M Q4 25Q1 26: -$5.7M -$5.7M Q1 26Q2 26: -$5.3M -$5.3M Q2 26Q3 26: $7.8M $7.8M Q3 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q3 FY2026June 30, 2026--$7.8M$0.08
Q2 FY2026March 31, 2026---$5.3M-$0.06
Q1 FY2026December 31, 2025---$5.7M-$0.06
Q4 FY2025September 30, 2025---$9.8M-
Q3 FY2025June 30, 2025---$13.2M-$0.16
Q2 FY2025March 31, 2025---$11.2M-$0.13
Q1 FY2025December 31, 2024---$12.1M-$0.14
Q4 FY2024September 30, 2024---$11.6M-

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Get an email when AVXL reports

Follow AVXL and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when AVXL files with the SEC.

Source: quarterly figures Anavex Life Sciences Corp. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Anavex Life Sciences Corp.